Immunovant, Inc. (IMVT) — Shares Outstanding

Annual figures by fiscal year, from SEC filings.

2019: 38.59M2020: 54.66M2021: 97.97M2022: 116.48M2023: 130.33M2024: 145.58M2025: 170.11M2026: 203.94M203.94M
2019Shares Outstanding (shares)2026
Fiscal YearShares OutstandingChange YoY
2026203.94M+19.9%
2025170.11M+16.8%
2024145.58M+11.7%
2023130.33M+11.9%
2022116.48M+18.9%
202197.97M+79.3%
202054.66M+41.6%
201938.59M